Results 1 to 10 of about 115,566 (252)

New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges. [PDF]

Frontiers in Microbiology, 2012
The commensal fungus Candida albicans causes mucosal candidiasis in the rapidly expanding number of immunocompromised patients. Mucosal candidiasis includes orapharyngeal, esophageal, gastrointestinal, and vaginal infections.
Anna eVecchiarelli, Eva ePericolini, Elena eGabrielli, Donatella ePietrella   +3 more
doaj   +2 more sources

Metabolomic profiling reveals alterations in Candida pathophysiology and host interactions during primary oral candidiasis and following antifungal treatment [PDF]

Scientific Reports
Comparative metabolomics may shed light on host immunity and biology in oral candidiasis (oral thrush). Untargeted metabolomic analyses were performed on oral rinses collected from 26 primary oral candidiasis patients (OT), 12 patients after antifungal ...
Nuramirah Azizan, Anis Rageh Al-Maleki, Mohd Salleh Rofiee, Alexandria Sonia Karajacob, Mun Fai Loke, Joanne Pei En Goh, Thomas George Kallarakkal, Wan Himratul Aznita Wan Harun, Rathna Devi Vaithilingam, Lay Kek Teh, Mohd Zaki Salleh, Sun Tee Tay   +11 more
doaj   +2 more sources

FACTORS ASSOCIATED WITH VAGINAL CANDIDIASIS AMONG PREGNANT WOMEN AT KAWAALA HEALTH CENTRE IV, KAMPALA DISTRICT. A CROSS-SECTIONAL DESCRIPTIVE STUDY.

Student's Journal of Health Research Africa, 2023
Introduction: Vaginal candidiasis refers to a fungal infection that causes irritation, discharge, and intense itchiness of the vagina. This study assessed the factors associated with Vaginal Candidiasis among pregnant women at Kawaala Health Centre IV ...
Livingstone Kawenyera
doaj   +1 more source

Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources

The Lancet Regional Health. Europe, 2022
Summary: Background: Biologics directed against the T-helper (Th)-17 pathway have been approved for several inflammatory diseases. Interleukin (IL)-17 is involved in anti-Candida host defense, and clinical trials suggested increased candidiasis ...
Linda Davidson, Juul M.P.A. van den Reek, Mariolina Bruno, Florence van Hunsel, Ron M.C. Herings, Vasiliki Matzaraki, Collins K. Boahen, Vinod Kumar, Hans M.M. Groenewoud, Frank L. van de Veerdonk, Mihai G. Netea, Elke M.G.J. de Jong, Bart Jan Kullberg   +12 more
doaj   +1 more source

Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis

SAGE Open Medicine, 2022
Vulvovaginal candidiasis is a common infection associated most often with the overgrowth of the fungal species Candida albicans . Although most women will have at least one episode of vulvovaginal candidiasis in their lifetime, some will experience ...
Chemen M Neal, Mark G Martens
doaj   +1 more source

Oral Microbiota Composition and Function Changes During Chronic Erythematous Candidiasis

Frontiers in Cellular and Infection Microbiology, 2021
Oral microbiota is constantly changing with the host state, whereas the oral microbiome of chronic erythematous candidiasis remains poorly understood. The aim of this study was to compare oral microbial signatures and functional profiling between chronic
Xin Lyu, Hui Zheng, Xu Wang, Xu Wang, Heyu Zhang, Lu Gao, Zhe Xun, Qian Zhang, Xuesong He, Hong Hua, Zhimin Yan, Feng Chen   +11 more
doaj   +1 more source

Splenectomy for treating hepatosplenic candidiasis: Two cases and literature review suggesting its feasibility

Heliyon, 2023
Background: Hepatosplenic candidiasis is a rare but severe complication in immunocompromised patients undergoing chemotherapy. Antifungal agents are widely accepted as the first choices for therapy.
Songfeng Yu, Yanling Ren, Xue Wen, Yufu Ye, Longyu Cheng, Jun Yu, Shusen Zheng   +6 more
doaj   +1 more source

Recurrent urogenital candidiasis: diagnosis and treatment

Медицинский совет, 2015
Vulvovaginal candidiasis is the most common manifestation of urogenital candidiasis. The disease is widespread among women of reproductive age. The disease recurs in 5-10% of cases.
A. M. Savicheva, E. V. Shipitsyna
doaj   +1 more source

Human immunodeficiency virus and Candida albicans co-infection in Iran: a systematic review

HIV & AIDS Review. International Journal of HIV-Related Problems, 2023
Candidiasis is one of serious problems in immunosuppressed patients, including HIV patients. Candida albicans is a fungi causing different humans diseases.
Saber Soltani, Abbas Farahani, Arghavan Zebardast, Razieh Dowran, Milad Zandi, Zahra Rafat, Elahe Sasani, Bahman Zarandi, Mohammad Pahlevan Fallahy, Mojtaba Didehdar   +9 more
doaj   +1 more source

Vaginal yeasts in the era of "over the counter" antifungals [PDF]

, 2000
OBJECTIVE: To establish whether there has been any rise in the prevalence of non-albicans Candida species isolated from vaginal swabs since the introduction of “over the counter” antifungal treatments.
Ashbee, H.R., Brown, C., Evans, E.G.V., Reynolds, M.T., Walker, P.P.   +4 more
core   +8 more sources